Skip to main content

Stampacchia Otello's Form 4 filing

Lexeo Therapeutics, Inc. (LXEO) · filed Nov 9, 2023

Accession no.
0001209191-23-054913
Filed
Nov 9, 2023, 8:36 PM ET
Trade date
Nov 7, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $5.00M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Stampacchia OtelloCIK 000136171210% Owner
Paster Anne-MariCIK 000165286310% Owner
Nessi ClaudioCIK 000172205010% Owner
Omega Fund VI, L.P.CIK 000175791710% Owner
Omega Fund VI GP Manager, Ltd.CIK 000182658410% Owner
Omega Fund VI GP, L.P.CIK 000182659210% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 7, 2023Common StockCConversionAcquired+1,415,865––1,415,865Direct
Nov 7, 2023Common StockCConversionAcquired+287,213––1,703,078Direct
Nov 7, 2023Common StockPPurchaseAcquired+454,545$11.00+$4,999,9952,157,623Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 7, 2023Common StockCConversionDisposed−1,415,865––0Direct
Nov 7, 2023Common StockCConversionDisposed−287,213––0Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)